Click on a filter below to refine your search. Remove a filter to broaden your search.
Baricitinib plus remdesivir was linked to a reduced risk of death and progression to invasive mechanical ventilation.
No significant reduction was seen in the percent of patients with urgent care or emergency department visits or hospitalization.
Molnupiravir and nirmatrelvir-ritonavir combination therapy should be considered for patients within five days of symptom onset.